Export 39 results:
Author [ Title
Filters: Author is VanVeldhuisen, Paul C [Clear All Filters]
“The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results.”, Ophthalmology, vol. 111, no. 4, pp. 651-64, 2004.
, “The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.”, Ophthalmology, vol. 111, no. 11, pp. 2109-16, 2004.
, “Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.”, Graefes Arch Clin Exp Ophthalmol, vol. 239, no. 7, pp. 1839-1851, 2021.
, “Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.”, JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
, “Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.”, Ophthalmology, vol. 118, no. 2, pp. 345-52, 2011.
, “Characteristics associated with severe perineal and cervical lacerations during vaginal delivery.”, Obstet Gynecol, vol. 117, no. 3, pp. 627-35, 2011.
, , “Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials.”, Transl Vis Sci Technol, vol. 10, no. 12, p. 28, 2021.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Denver, Colorado, 2021.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.”, JAMA, vol. 317, no. 20, pp. 2072-2087, 2017.
, “Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.”, JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
, “Hair analysis and its concordance with self-report for drug users presenting in emergency department.”, Drug Alcohol Depend, vol. 167, pp. 149-55, 2016.
, “Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.”, JAMA Ophthalmol, vol. 133, no. 9, pp. 1022-9, 2015.
, “Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.”, JAMA Ophthalmol, vol. 139, no. 12, pp. 1285-1291, 2021.
, “LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.”, Retina, vol. 39, no. 9, pp. 1802-1809, 2019.
, , ,
“Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica.”, J Infect Dis, vol. 194, no. 5, pp. 552-60, 2006.
, ,
“Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.”, Am J Drug Alcohol Abuse, vol. 37, no. 5, pp. 350-7, 2011.
, “Prescription opioid registry protocol in an integrated health system.”, Am J Manag Care, vol. 23, no. 5, pp. e146-e155, 2017.
, “A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus”, Arch Ophthalmol, vol. 127, no. 9, pp. 1101-14, 2009.
, “SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.”, Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
,